Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 42 Small Cell Lung Carcinoma 19 Breast Neoplasms 16 Sarcoma 12 Lung Neoplasms 9 Esophageal Squamous Cell Carcinoma 7 Carcinoma, Hepatocellular 7 Thyroid Neoplasms 6 Stomach Neoplasms 6 Nasopharyngeal Carcinoma 6 Esophageal Neoplasms 6 Ovarian Neoplasms 5 NSCLC 5 Carcinoma 5 Triple Negative Breast Neoplasms 4 Pheochromocytoma 4 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Recurrence 3 Paraganglioma 3 Neoplasms 3 Glioma 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Biliary Tract Neoplasms 3 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Platinum-resistant Ovarian Cancer 2

Interventions

pembrolizumab 3 lenvatinib 3 gallium 68 PSMA-11 2 apatinib 2 Protons 2 Magnetic Resonance Spectroscopy 2 Imatinib Mesylate 2 Epirubicin 2 Cisplatin 2 Carboplatin 2 Axitinib 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 tislelizumab 1 regorafenib 1 enfortumab vedotin 1 cabozantinib 1 avelumab 1 anlotinib 1 amivantamab 1 abemaciclib 1 Tretinoin 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1 Pemetrexed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Adenoid Cystic × anlotinib × Clear all

NCT07616141 2026-06-01

NAET4-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Not yet recruiting

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡